Lijst van brutoformules C100

Dit lemma is een onderdeel van de lijst van brutoformules met 100 en meer koolstofatomen. Sjabloon:Inhoud horizontaal

Brutoformule	Naam
$\mathrm{C}{\phantom{A}}_{120}\mathrm{O}$	Fullereen(120)monooxide ~ in Subkop: "Polymere koolstofoxides" van "Koolstofoxide (stofgroep)"
$\mathrm{C}{\phantom{A}}_{120}\mathrm{O}{\phantom{A}}_4$	Fullereentetr(120)tetroxide ~ in Subkop: "Polymere koolstofoxides" van "Koolstofoxide (stofgroep)"
$\mathrm{C}{\phantom{A}}_{129}\mathrm{H}{\phantom{A}}_{223}\mathrm{N}{\phantom{A}}_3\mathrm{O}{\phantom{A}}_{54}$	Palytoxine
$\mathrm{C}{\phantom{A}}_{131}\mathrm{H}{\phantom{A}}_{229}\mathrm{N}{\phantom{A}}_{39}\mathrm{O}{\phantom{A}}_{31}$	Mellitine
$\mathrm{C}{\phantom{A}}_{140}\mathrm{O}$	Fullereentetr(140)oxide ~ in Subkop: "Polymere koolstofoxides" van "Koolstofoxide (stofgroep)"
$\mathrm{C}{\phantom{A}}_{143}\mathrm{H}{\phantom{A}}_{230}\mathrm{N}{\phantom{A}}_{42}\mathrm{O}{\phantom{A}}_{37}\mathrm{S}{\phantom{A}}_7$	Nisine
$\mathrm{C}{\phantom{A}}_{148}\mathrm{H}{\phantom{A}}_{281}\mathrm{N}{\phantom{A}}_{50}\mathrm{O}{\phantom{A}}_{60}\mathrm{S}$	Exenatide
$\mathrm{C}{\phantom{A}}_{153}\mathrm{H}{\phantom{A}}_{225}\mathrm{N}{\phantom{A}}_{43}\mathrm{O}{\phantom{A}}_{49}\mathrm{S}$	Glucagon
$\mathrm{C}{\phantom{A}}_{164}\mathrm{H}{\phantom{A}}_{256}\mathrm{N}\mathrm{a}{\phantom{A}}_2\mathrm{O}{\phantom{A}}_{68}\mathrm{S}{\phantom{A}}_2$	Maitotoxine
$\mathrm{C}{\phantom{A}}_{187}\mathrm{H}{\phantom{A}}_{291}\mathrm{N}{\phantom{A}}_{45}\mathrm{O}{\phantom{A}}_{59}$	Semaglutide
$\mathrm{C}{\phantom{A}}_{204}\mathrm{H}{\phantom{A}}_{263}\mathrm{N}{\phantom{A}}_{63}\mathrm{O}{\phantom{A}}_{114}\mathrm{P}{\phantom{A}}_{20}\mathrm{S}{\phantom{A}}_{20}$	Fomivirsen
$\mathrm{C}{\phantom{A}}_{228}\mathrm{H}{\phantom{A}}_{236}\mathrm{F}{\phantom{A}}_{72}\mathrm{N}{\phantom{A}}_{12}\mathrm{O}{\phantom{A}}_{30}\mathrm{P}{\phantom{A}}_{12}$	Olympiadaan
$\mathrm{C}{\phantom{A}}_{234}\mathrm{H}{\phantom{A}}_{323}\mathrm{N}{\phantom{A}}_{61}\mathrm{N}\mathrm{a}{\phantom{A}}_{17}\mathrm{O}{\phantom{A}}_{128}\mathrm{P}{\phantom{A}}_{17}\mathrm{S}{\phantom{A}}_{17}$	Nusinersen
$\mathrm{C}{\phantom{A}}_{254}\mathrm{H}{\phantom{A}}_{377}\mathrm{N}{\phantom{A}}_{65}\mathrm{O}{\phantom{A}}_{75}\mathrm{S}{\phantom{A}}_6$	Insuline
$\mathrm{C}{\phantom{A}}_{256}\mathrm{H}{\phantom{A}}_{387}\mathrm{N}{\phantom{A}}_{65}\mathrm{O}{\phantom{A}}_{79}\mathrm{S}{\phantom{A}}_6$	Insuline aspart
$\mathrm{C}{\phantom{A}}_{257}\mathrm{H}{\phantom{A}}_{387}\mathrm{N}{\phantom{A}}_{65}\mathrm{O}{\phantom{A}}_{76}\mathrm{S}{\phantom{A}}_6$	Actrapid
$\mathrm{C}{\phantom{A}}_{257}\mathrm{H}{\phantom{A}}_{389}\mathrm{N}{\phantom{A}}_{65}\mathrm{O}{\phantom{A}}_{77}\mathrm{S}{\phantom{A}}_6$	Insuline lispro
$\mathrm{C}{\phantom{A}}_{267}\mathrm{H}{\phantom{A}}_{402}\mathrm{N}{\phantom{A}}_{64}\mathrm{O}{\phantom{A}}_{76}\mathrm{S}{\phantom{A}}_6$	Insuline detemir
$\mathrm{C}{\phantom{A}}_{267}\mathrm{H}{\phantom{A}}_{408}\mathrm{N}{\phantom{A}}_{72}\mathrm{O}{\phantom{A}}_{77}\mathrm{S}{\phantom{A}}_6$	Insuline glargine
$\mathrm{C}{\phantom{A}}_{815}\mathrm{H}{\phantom{A}}_{1317}\mathrm{N}{\phantom{A}}_{233}\mathrm{O}{\phantom{A}}_{241}\mathrm{S}{\phantom{A}}_5$	Aranesp
$\mathrm{C}{\phantom{A}}_{845}\mathrm{H}{\phantom{A}}_{1343}\mathrm{N}{\phantom{A}}_{223}\mathrm{O}{\phantom{A}}_{243}\mathrm{S}{\phantom{A}}_9$	Filgrastim
$\mathrm{C}{\phantom{A}}_{908}\mathrm{H}{\phantom{A}}_{1408}\mathrm{N}{\phantom{A}}_{246}\mathrm{O}{\phantom{A}}_{252}\mathrm{S}{\phantom{A}}_7$	Interferon bèta-1a
$\mathrm{C}{\phantom{A}}_{908}\mathrm{H}{\phantom{A}}_{1408}\mathrm{N}{\phantom{A}}_{246}\mathrm{O}{\phantom{A}}_{253}\mathrm{S}{\phantom{A}}_6$	Interferon bèta-1b
$\mathrm{C}{\phantom{A}}_{1214}\mathrm{H}{\phantom{A}}_{1890}\mathrm{N}{\phantom{A}}_{338}\mathrm{O}{\phantom{A}}_{348}\mathrm{S}{\phantom{A}}_{14}$	Ocriplasmine
$\mathrm{C}{\phantom{A}}_{2131}\mathrm{H}{\phantom{A}}_{3299}\mathrm{N}{\phantom{A}}_{555}\mathrm{O}{\phantom{A}}_{671}\mathrm{S}{\phantom{A}}_{11}$	Idarucizumab
$\mathrm{C}{\phantom{A}}_{2224}\mathrm{H}{\phantom{A}}_{3475}\mathrm{N}{\phantom{A}}_{621}\mathrm{O}{\phantom{A}}_{698}\mathrm{S}{\phantom{A}}_{36}$	Etanercept
$\mathrm{C}{\phantom{A}}_{2532}\mathrm{H}{\phantom{A}}_{3850}\mathrm{N}{\phantom{A}}_{672}\mathrm{O}{\phantom{A}}_{711}\mathrm{S}{\phantom{A}}_{16}$	Velaglucerase alfa
$\mathrm{C}{\phantom{A}}_{3498}\mathrm{H}{\phantom{A}}_{5458}\mathrm{N}{\phantom{A}}_{922}\mathrm{O}{\phantom{A}}_{1090}\mathrm{S}{\phantom{A}}_{32}$	Abatacept
$\mathrm{C}{\phantom{A}}_{4318}\mathrm{H}{\phantom{A}}_{6788}\mathrm{N}{\phantom{A}}_{1164}\mathrm{O}{\phantom{A}}_{1304}\mathrm{S}{\phantom{A}}_{32}$	Aflibercept
$\mathrm{C}{\phantom{A}}_{4758}\mathrm{H}{\phantom{A}}_{7262}\mathrm{N}{\phantom{A}}_{1274}\mathrm{O}{\phantom{A}}_{1369}\mathrm{S}{\phantom{A}}_{35}$	Alglucosidase alfa
$\mathrm{C}{\phantom{A}}_{5020}\mathrm{H}{\phantom{A}}_{7588}\mathrm{N}{\phantom{A}}_{1364}\mathrm{O}{\phantom{A}}_{1418}\mathrm{S}{\phantom{A}}_{34}$	Elosulfase alfa
$\mathrm{C}{\phantom{A}}_{6416}\mathrm{H}{\phantom{A}}_{9874}\mathrm{N}{\phantom{A}}_{1688}\mathrm{O}{\phantom{A}}_{1987}\mathrm{S}{\phantom{A}}_{44}$	Rituximab
$\mathrm{C}{\phantom{A}}_{6428}\mathrm{H}{\phantom{A}}_{9912}\mathrm{N}{\phantom{A}}_{1694}\mathrm{O}{\phantom{A}}_{1987}\mathrm{S}{\phantom{A}}_{46}$	Infliximab
$\mathrm{C}{\phantom{A}}_{6428}\mathrm{H}{\phantom{A}}_{9976}\mathrm{N}{\phantom{A}}_{1720}\mathrm{O}{\phantom{A}}_{2018}\mathrm{S}{\phantom{A}}_{32}$	Tocilizumab
$\mathrm{C}{\phantom{A}}_{6472}\mathrm{H}{\phantom{A}}_{10028}\mathrm{N}{\phantom{A}}_{1740}\mathrm{O}{\phantom{A}}_{2014}\mathrm{S}{\phantom{A}}_{46}$	Aducanumab
$\mathrm{C}{\phantom{A}}_{6482}\mathrm{H}{\phantom{A}}_{10004}\mathrm{N}{\phantom{A}}_{1712}\mathrm{O}{\phantom{A}}_{2016}\mathrm{S}{\phantom{A}}_{46}$	Ustekinumab
$\mathrm{C}{\phantom{A}}_{6534}\mathrm{H}{\phantom{A}}_{10004}\mathrm{N}{\phantom{A}}_{1716}\mathrm{O}{\phantom{A}}_{2036}\mathrm{S}{\phantom{A}}_{46}$	Pembrolizumab
$\mathrm{C}{\phantom{A}}_{6638}\mathrm{H}{\phantom{A}}_{10160}\mathrm{N}{\phantom{A}}_{1720}\mathrm{O}{\phantom{A}}_{2108}\mathrm{S}{\phantom{A}}_{44}$	Bevacizumab
$\mathrm{C}{\phantom{A}}_{6760}\mathrm{H}{\phantom{A}}_{10447}\mathrm{N}{\phantom{A}}_{1743}\mathrm{O}{\phantom{A}}_{2010}\mathrm{S}{\phantom{A}}_{32}$	Botulinetoxine A